Chemotherapy-Free Approach in Relapsed/Refractory AML: Antibody-Drug Conjugates, Dual Affinity Re-Targeting (DART) and Bi-Specific T-Cell Engagers (BiTEs)

305 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login